Biotech China 2014
The 8th World Drug Discovery & Development Summit 2008
Corinthia Towers Hotel Prague
Kongresova 1
Prague,
http://

Schedule of Presentations:

Tuesday, December 2, 2008
08:00:00 Delegate registration
08:25:00 Chairman's introduction Prof. Ian Wilson
08:30:00 R&D RISK MANAGEMENT - THE INTEGRATED APPROACH Bernd Seilheimer
09:00:00 DRUG REPOSITIONING STRATEGIES THROUGHOUT THE PRODUCT PORTFOLIO Dean J Welsch
09:30:00 DEVELOPING AN IMPROVED IN VITRO SYSTEM TO PREDICT DRUG-INDUCED LIVER INJURY IN MAN Prof. Jürgen Borlak
10:00:00 Pre-scheduled one-to-one meetings
11:20:00 NDUSTRY - ACADEMIC COLLABORATIONS : BRIDGING TWO WORLDS FOR MUTUAL BENEFIT Samantha O'Connor
11:20:00 NEW STRATEGIES TO IDENTIFY SAFETY LIABILITIES EARLY Thomas Singer
12:00:00 IDENTIFYING HUMAN DRUG METABOLITES FOR TOXICITY TESTING - METABOLITES IN THE MIST Prof. Ian Wilson
12:00:00 CREATING A COLLABORATIVE PHARMA MODEL - BENEFITING FROM A NETWORK OF MINDS
12:40:00 Networking luncheon
13:50:00 PREDICTING DRUG PROMISCUITY Jacques Hamon
13:50:00 OUT-SOURCING MEDICINAL CHEMISTRY TO ASIA
14:30:00 Pre-scheduled one-to-one meetings
16:15:00 CHALLENGES FOR MEDICINAL CHEMISTS IN SUCCESSFUL AND EFFECTIVE COLLABORATIONS AND PARTNERSHIPS IN DRUG DISCOVERY Giuseppe Giardina
16:15:00 ALTERNATIVE MODELS FOR TOXICITY TESTING: ZEBRAFISH Carles Callol
17:15:00 N SILICO MODELLING OF DRUG-TARGET INTERACTIONS
17:15:00 'THE BENEFITS OF USING HIGH RESOLUTION, HIGH SENSITIVITY NUCLEAR MOLECULAR IMAGING IN THE DRUG DEVELOPMENT PROCESS' & 'MOLECULAR IMAGING IN DRUG DEVELOPMENT USING HIGH RESOLUTION NanoSPECT/CT' York Haemisch
18:15:00 DRUG PRICING AND REIMBURSEMENT
18:45:00 Chairman's closing remarks and drinks reception
Wednesday, December 3, 2008
08:00:00 Delegate registration
08:25:00 Chairman's introduction Jinghai Xu
08:30:00 BRINGING SPEED AND SURVIVAL TO DRUG DISCOVERY AND DEVELOPMENT THROUGH CONTINUOUS IMPROVEMENT Andrew Seddon
09:00:00 APPLICATIONS OF SYSTEMS BIOLOGY IN TARGET IDENTIFICATION AND TOXICITY SCREENING Jinghai Xu
09:30:00 IS THE FUTURE OF PHARMA IN PERSONALISED MEDICINE? Thomas Metcalfe
10:00:00 Morning refreshments
10:30:00 BEYOND MONOCLONAL ANTIBODIES Andy Popplewell
10:30:00 HCS VS HTS – DEVELOPING A COMPLEMENTARY DRUG DISCOVERY MODEL Jonathan Lee
11:10:00 THE INDUSTRIALISATION OF CELLULAR SCREENING Alan Wise
11:10:00 UNLEASHING THE POTENTIAL OF RNAi
11:50:00 COMPUTER-AIDED DRUG DESIGN
11:50:00 STREAMLINING BIOPRODUCTION R&D Berthold Bödeker
12:30:00 Themed luncheon discussions
13:50:00 DATA INTEGRATION FOR MULTI SITE MANAGEMENT
13:50:00 IMPLEMENTING IMPROVED SCREENING TECHNOLOGIES
14:50:00 CONSTRUCTING AND IMPLEMENTING AN ADVANCED BIOLOGICAL AND CHEMICAL DISCOVERY INFORMATICS PLATFORM
14:50:00 STRUCTURE-BASED DRUG DISCOVERY: FROM FRAGMENT TO CLINICAL CANDIDATE Andrew Woodhead
15:30:00 TACKLING THE THREAT OF COMPOUND-RELATED TOXICOLOGICAL ATTRITION IN MEDICINAL CHEMISTRY Jonathan Mason
15:30:00 COMPUTATIONAL SYSTEMS BIOLOGY
16:10:00 STREAMLINING PROCESSES IN DISCOVERY AND DEVELOPMENT Clare Hammond
16:40:00 Chairman's closing remarks and close of conference
4th Annual Pharma R&D Asia Congress
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community
BiotechScienceNews.com promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.